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understand the molecular basis of T cell recognitionMolecular Interactions:
based on crystal structures of TCR/MHC complexes andStiff or Floppy analysis of the kinetics and thermodynamics of these
interactions (Rudolph et al., 2002).(or Somewhere in Between?)
Dilemmas have arisen in both the NK and TCR recog-
nition arenas: how do some NK receptors manage to
bind several different MHCp or MHCI-like molecules that
Recognition of MHC and MHC-like molecules by both only show some 20% identity in linear amino acid se-
natural killer (NK) and T cell receptors (TCR) reveals quence? How do some TCR bind distinct MHCp com-
remarkable degeneracy. The interaction of the NKG2D plexes in which the bound peptides are quite different,
NK receptor with several MHC I-like ligands has now or interact with MHC molecules of different alleles or
been analyzed thermodynamically by McFarland and species?
Strong, who suggest that a “rigid adaptation” mecha- The latest chapter in this ongoing tale of the molecular
nism governs such crossreactivity. This contrasts with basis of degenerate recognition by the C-type lectin
“induced fit” that accounts for TCR adaptation to mul- like NK receptor, NKG2D, is reported in this issue of
tiple MHCp ligands. Immunity (McFarland and Strong, 2003). NKG2D is a
homodimeric, type II membrane protein, characteristi-
The best understood of the cell surface receptors that cally expressed on NK cells, some NK T cells,  T cells,
govern immune recognition by natural killer (NK) cells resting CD8T cells [this is true only for humans;
and T lymphocytes exploit either C-type lectin-like or mouse CD8 T cells must be activated before expressing
immunoglobulin-like scaffolds to support structures that NKG2D], and resting macrophages that are associated
bind either MHC I-like molecules or classical MHC/pep- with a signal transducing subunit, either DAP10 or
tide (MHCp) complexes. The interaction of NK receptors DAP12 (Raulet, 2003). Ligands of NKG2D, though some-
with MHC class I-peptide (MHCIp) or with MHC I-like what different in the mouse and human, have several
molecules activates costimulatory or inhibitory path- features in common: they reveal structural similarity to
ways, depending on the particular NK receptor engaged the classical 12 domain unit of classical MHCI mole-
and the physiological state of the effector cell (Raulet, cules (though they lack bound peptide or a peptide bind-
2003). Recent efforts to understand the interaction of ing groove), and they seem to be expressed in response
NK receptors with MHC molecules have included X-ray to various kinds of cellular stress such as heat shock,
structure determination of a number of NK receptor/ tumor transformation, and bacterial or viral infection. In
MHC complexes and detailed studies of various NK re- the human, NKG2D binds the peptide-free epithelial cell
ceptors binding to their MHCIp or MHC I-like ligands expressed MHCI-like molecules, MIC-A and MIC-B
(Bauer et al., 1999). These are cell surface molecules(Natarajan et al., 2002). These studies parallel efforts to
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Figure 1. Schematic Illustration of Three Dif-
ferent Mechanisms for Receptor/Ligand In-
teractions
The binding surfaces of a receptor, R and its
ligand, L, are illustrated for each of the three
models, induced fit, rigid adaptation, and
lock-and-key. Three different modes of in-
duced fit are illustrated: one in which only the
ligand, L, changes conformation on binding
to L; one in which the receptor itself, R,
changes on binding, and a third in which both
receptor R″ and ligand L″ undergo conforma-
tional change. For rigid adaptation, modest
conformation change outside of the binding
site may occur for the receptor (R goes to
R″), but different ligands do not undergo con-
formational change. An example of lock-and-
key recognition of degenerate ligands is
shown where subsites A and B on the recep-
tor and the respective subsites A on one li-
gand and B on a second ligand are shown.
Structural and binding characteristics of the
three modes of interaction and examples of
each are tabulated.
with MHCI-like 1,2, and 3 domains that lack the 2- binding. Mutagenesis studies in two laboratories
(McFarland et al., 2003; Radaev et al., 2002) confirmedmicroglobulin subunit characteristic of classical MHCI
molecules. Significant amounts of soluble MIC mole- that the NKG2D receptor utilizes different strategies to
interact with each of its targets.cules can be found in the serum of patients with epithe-
lial tumors (Groh et al., 2002). Other NKG2D ligands of In structural terms, how can one explain degenerate
recognition such as that seen with NKG2D? There arethe human include distantly related MHCI-like molecules
known as ULBP1, 2, and 3 that only have 1 and 2 two extreme models (illustrated in Figure 1): (1) induced
fit, in which the receptor adjusts conformationally todomains and that are linked to the cell surface via a
glycophosphatidyl-inositol (GPI) anchor, as well as the allow the formation of a stable complex; or (2) rigid lock-
and-key, in which the receptor remains in precisely thesimilarly sized and structured RAET1 molecules (includ-
ing ULBP4 or RAET1E) that have genuine transmem- same conformation before and after interaction with a
rigid ligand, preserving strict shape and/or charge com-brane domains. The human NKG2D seems to be univer-
sally associated with DAP10, a signal transducing plementarity. For model 1, conformational adjustment
of one or more loops and/or amino acid side chains ismolecule with a YXXM motif that mediates activation
through a PI3 kinase pathway. The mouse NKG2D mole- required to yield the match needed for a stable complex.
Variations of model 1 include those in which the ligandcule also binds stress associated MHCI-like molecules,
Rae-1, H-60, or MULT1. MuNKG2D is expressed as dif- changes its conformation, either with or without the ad-
justment of the receptor. For a rigid receptor to interactferent isoforms that interact either with DAP10, as in
the human, or with DAP12, allowing signaling through with multiple distinct ligands as in model 2, the partners
must satisfy shape and charge complementarity require-a ZAP70 or SYK pathway.
The X-ray structures of both murine (Wolan et al., ments, although this may be accomplished in different
ways. For example, if the receptor has binding subsites2001) and human (McFarland et al., 2003) NKG2D as
well as complexes consisting of huNKG2D and MIC-A A and B, ligand 1 might have a complementary subsite
A, while ligand 2 could have a distinct complementary(Li et al., 2001), huNKG2D and ULBP3 (Radaev et al.,
2001), and muNKG2D and Rae-1 (Li et al., 2002) have subsite B. This is acceptable as long as other parts
of the receptor-ligand interface are not disruptive orbeen solved and offer a tangible, static view of how a
single receptor can interact with multiple ligands. The inhibitory to the interaction. Strictly speaking, compari-
son of the structures of the receptor and ligand in theNKG2D homodimer uses each of its monomers to inter-
act asymmetrically with either the 1 helix or the car- free and bound states should be sufficient to substanti-
ate either of the extreme models. Indeed, initial interpre-boxyl half of the 2 helix of its MHCI-like ligands, in
a general orientation similar to that of the TCR/MHCp tation of the NKG2D/ULBP3 structure suggested an in-
duced fit mechanism. More recently, however, with theinteraction. The two identical subunits of the NKG2D
homodimer use different residues to mediate interaction availability of the unliganded huNKG2D structure,
McFarland et al. (2003) favored a view in which NKG2Dwith each of the  helices of their ligands.. Furthermore,
direct comparison of the interactions of huNKG2D with flexibility plays a minor role.
Resolution of a controversy often derives from a newMIC-A and ULBP3 demonstrated that largely nonover-
lapping subsets of contact residues are employed by avenue of experimentation, and for NKG2D the fruitful
approach has been to examine the thermodynamics ofthe huNKG2D to bind the latter two molecules. Thus
analysis of the three different receptor-ligand structures the binding of muNKG2D with Rae-1 and of huNKG2D
with MIC-A, MIC-B, and ULBP1. Early kinetic bindingprovides information on six different modes of NKG2D
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studies of TCR/MHCp suggested slow association rate nine, and arginine residues on different ligands, as well
as to form hydrogen bonds to disparate residues in theconstants, a hint that conformational adjustment (or in-
duced fit) might be needed (Corr et al., 1994). NKG2D/ six different ligand sites examined. Thus, exploring the
ligand complex formation was more rapid, consistent interaction of NKG2D with several ligands both structur-
with rigid body interactions. A simple binding analysis ally and thermodynamically has revealed the evolution-
would yield an equilibrium dissociation constant (KD), ary adaptation of this NK receptor to productive associa-
and thus the change in free energy on binding given by tion with multiple targets. Other receptors with a similar
Go  - ln KD.. Such an analysis would not in itself tell mechanism of degenerate recognition are sure to be
us anything about the mechanism of binding. However, found.
by evaluation of the binding parameters as a function
of temperature, following an approach recently applied
David H. Margulies
to TCR/MHCp binding in two laboratories (Boniface et
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